November 16, 2023 @ 1:00 PM – 2:00 PM
Join Noble Life Sciences on Thursday, November 16th for an insightful webinar, “Navigating Cell Therapy Product Development: From Proof of Concept to IND Enabling Studies,” featuring the expertise of CSO Stephen Horrigan. In this webinar, you will gain invaluable insights into the intricate world of cell therapy product development, from the initial proof of concept to the crucial IND enabling studies.
Date: November 16th
Time: 1:00PM ET
Register for Meeting Link: https://share.hsforms.com/1kaJhuKTfTMe63pFC3fMl4g2l4jw?__hstc=78668683.efba821d3019da0f27511d3f71e793fa.1695665484018.1698722752631.1698844469134.61&__hssc=78668683.3.1698844469134&__hsfp=1445259321
In this webinar you will learn about:
* The current challenges in cell therapy development.
* What it takes to develop successful proof of concept in vitro and preclinical studies.
* Which key regulatory factors you need to condition when preparing an IND application.
* How to develop a robust IND package.
* Strategies for IND-enabling nonclinical safety and toxicology studies.
* The importance of Quality Control (QC) in cell therapy.
* Recent cell therapy innovations and emerging technologies.